Improvement in Long COVID Symptoms in Two Individuals Treated with Baricitinib

Long COVID is a potentially disabling syndrome that currently lacks effective treatments.We describe two individuals with Long COVID-associated arthralgias, anginal chest pain and evidence of sub-endocardial ischemia by adenosine-stress cardiac magnetic resonance, whose symptoms improved with the Janus-Kinase 1/2 inhibitor baricitinib.

Publication Details

Journal
Annals of Case Reports
Published
2024-08-21
DOI
https://doi.org/10.29011/2574-7754.101939
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Improvement in Long COVID Symptoms in Two Individuals Treated with Baricitinib

Annals of Case Reports
Long-Term Effects of COVID-19
article

Improvement in Long COVID Symptoms in Two Individuals Treated with Baricitinib

article en

Abstract

Long COVID is a potentially disabling syndrome that currently lacks effective treatments.We describe two individuals with Long COVID-associated arthralgias, anginal chest pain and evidence of sub-endocardial ischemia by adenosine-stress cardiac magnetic resonance, whose symptoms improved with the Janus-Kinase 1/2 inhibitor baricitinib.

Annals of Case ReportsVol. 9(4)
Zero hunger
Openalex Percentile: Top 78%
Long-Term Effects of COVID-19
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.